All Cancer Microbiology articles
-
NewsChemists use sea sponge bacteria to create new molecules for drug discovery
Chemists have synthesized new molecules derived from bacteria found in a Pacific Ocean sea sponge. They are the first to successfully synthesize two new marine natural products: tetradehydrohalicyclamine B and epi-tetradehydrohalicyclamine B.
-
NewsHPV self-collection boosts cervical cancer screening rates
The first major U.S. rollout of HPV self-collection shows benefits for patients and providers, including fewer pelvic exams and better follow-up for HPV-positive results.
-
NewsLargest-ever Canadian clinical trial tests ‘poop pills’ to improve immunotherapy for lung cancer
For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. A clinical trial will pair immunotherapy with fecal microbiota transplantation (FMT) with the goal of safely increasing treatment effectiveness. If successful, it could provide new treatment options for people with lung cancer.
-
Careers The First Microbiome Symposium of Puerto Rico and the Caribbean – new success for the COBRE Center for Microbiome Sciences
The inaugural Microbiome Symposium of Puerto Rico and the Caribbean marked a major milestone for microbiome science in the region and reinforced Puerto Rico’s growing leadership in interdisciplinary biomedical research, says chair Filipa Godoy-Vitorino of the University of Puerto Rico.
-
NewsStudy is first to detect and track multiple cancer-causing viruses in wastewater
A study is the first comprehensive approach to detect all known cancer-causing or oncogenic viruses concurrently by analyzing viral genomes in wastewater. The work shows that it is feasible to monitor the presence and levels of cancer-causing viruses, enabling the possibility of public health interventions in the future.
-
NewsBacteria may hold a cancer treatment clue
A review argues that tumors with reproducibly poor prognosis outcomes may share an overlooked feature: bacterial infection within the tumor microenvironment. These bacteria may weaken treatment by altering local immunity, damaging tissue structure, and even inactivating chemotherapeutic drugs.
-
NewsInfluenza virus platforms: New hope for vaccines and cancer immunotherapy
Influenza virus is now being engineered to carry foreign genes and reduce virulence, serving not only for next-generation influenza vaccines but also as delivery vectors for heterologous antigens against other infections and cancers, supported by its ability to trigger robust mucosal and systemic immune responses.
-
NewsResearchers develop realistic ‘mock’ samples to speed cervical cancer test development
A team of bioengineers has developed a new way to create highly realistic “mock” patient samples that could help accelerate the development of faster, more accessible cervical cancer screening tests for low-resource settings.
-
NewsScientists discover how gut bacteria toxin invades colon cells to trigger cancer
A common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. Researchers have now shown that the B. fragilis toxin BFT must first bind host receptor claudin-4 before it can cause damage.
-
NewsNew kind of CRISPR could treat viral infection and cancer by shredding sick cells’ DNA
A new technology uses a relative of the CRISPR-Cas9 gene editing system to kill target cells. When activated by a specific, programmable genetic target, the Cas12a2 protein rips a cell’s genome apart. Researchers programmed Cas12a2 to kill virus-infected cells or cancer cells while leaving healthy cells untouched.
-
NewsDisease-causing pathogen rewires gut metabolism to secure nutrients for growth
Enterotoxigenic Bacteroides fragilis (ETBF), which causes diarrhea and has been implicated in colitis and colorectal cancer, uses a toxin it produces to reprogram intestinal cell metabolism and generate conditions that support its growth.
-
NewsCervical cancer: A growing gap between high- and low-income countries
While high-income countries could eliminate cervical cancer by 2048 through human papillomavirus (HPV) vaccination and screening, the gap with lower-income countries is widening.
-
NewsScientists source anti-cancer treatment in bacteria
Researchers have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. The therapy is made from a fragment of a bacterial protein, a peptide called aurB. In cancer tumors in the animal models, aurB prevented energy production in the tumor cells’ mitochondria, essentially cutting off the tumor’s fuel.
-
NewsLifestyle, diet, and clinical factors shape the gut microbiome in cancer patients
Lifestyle factors, such as physical activity and dietary modifications can beneficially modulate the gut microbiome of cancer patients - however their effects are often shaped by non-modifiable variables.
-
NewsScientists highlight the cost of delaying childhood vaccination
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life. A new study found that the longer the delay, the higher the cost in human life and health care.
-
NewsSecret to a healthy liver found in a young microbiome
Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study.
-
NewsResearchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
-
NewsPioneering virologist Bernard Roizman dies at 96
Bernard Roizman, ScD, world-leading expert on herpes simplex virus (HSV) and Joseph Regenstein Distinguished Service Professor Emeritus of Microbiology and Molecular Genetics and Cell Biology at The University of Chicago, died on April 13, 2026, at the age of 96.
-
NewsOral-gut axis points to salivary biomarkers for early gastric cancer detection
A recent study has identified distinct microbial “signatures” within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer (GC). Research shows how specific lactic acid-producing bacteria (LAB) migrate from the mouth to colonize the gastrointestinal tract.
-
NewsGut bacteria predict skin cancer recurrence, but only when matched for ‘microbial fingerprint’
The specific mix of bacteria living in a person’s gut can predict the chances that melanoma will recur after surgery and immunotherapy, which helps immune cells target cancer cells, according to a new study.